Monday, January 12, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

NCR Voyix Faces Stock Market Turbulence After Unveiling Preliminary Financial Results

Elaine Mendonca by Elaine Mendonca
March 2, 2024
in Breaking News
0
Finances-and-tech
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

NCR Voyix has recently unveiled its preliminary financial results for the fourth quarter and full year of 2023, causing a stir in the stock market.

In Q4, the company suffered a net loss, with earnings per diluted share dropping to $2.25 from $0.15 the previous year. Despite seeing growth in software and services throughout 2023, NCR Voyix‘s Price to Earnings (P/E) Ratio remains in the negative at -3.93, indicating ongoing losses.

The spin-off of NCR Atleos has also played a role in the reported results, as discontinued operations have affected the overall financial picture. As a result, investors have reacted to the disclosed figures by causing a decline in the company’s shares.

As of March 2, 2024, NCR Voyix continues to navigate the challenges presented by its financial performance and market response.

VYX Stock Plunges 21.49% in Tumultuous Day on Market: Potential Rebound in After-Hours Trading

On March 2, 2024, VYX stock had a tumultuous day on the market. The stock closed at $11.47, which was a significant drop of $3.14, or 21.49%, from the previous market close. This put the stock near the bottom of its 52-week range and below its 200-day simple moving average, indicating a bearish trend for the stock.

However, there was a glimmer of hope for VYX investors as the stock rose $0.27 in after-hours trading. While this increase is modest compared to the earlier drop, it does suggest that there may be some buying interest in the stock after the initial sell-off.

VYX Stock Sees Significant Decrease in Revenue and Profitability in 2024

On March 2, 2024, VYX stock experienced a significant decrease in its financial performance compared to the previous year and the last quarter. According to data from CNN Money, the total revenue for VYX was $3.83 billion over the past year, which decreased by 51.17% from the previous year. In the fourth quarter of the year, the total revenue was $963.00 million, representing a decrease of 52.26% from the previous quarter.

Similarly, the net income for VYX was -$422.00 million over the past year, which decreased by 803.33% from the previous year. In the fourth quarter, the net income was -$254.00 million, showing a decrease of 104.84% from the previous quarter.

Furthermore, the earnings per share (EPS) for VYX were -$3.12 over the past year, which decreased by 1099.74% from the previous year. In the fourth quarter, the EPS was -$2.25, indicating a decrease of 147.57% from the previous quarter.

These financial indicators suggest that VYX has been facing challenges in generating revenue and profitability over the past year and the last quarter. Investors and analysts may be concerned about the company’s ability to improve its financial performance and turn the situation around in the future.

Tags: VYX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
COST stock news

Analysts Bullish on Veeva Systems Increase Price Target to 264

Pactiv Evergreen Q4 Financial Results Revenue Decline but Positive Outlook with Restructuring Plan

The Rise of Strategic Partnerships in Life Sciences: Trends Shaping the Future of Healthcare Innovation

Rambus Stock Price Surges with Accelerated Share Repurchase Program

Recommended

Upcoming FDA Advisory Committee Meeting for Imetelstat A Groundbreaking Treatment for Malignant Stem Cells

2 years ago
Portillo's Stock

Leadership Turmoil Sends Portillo’s Shares to New Low

2 months ago
Dine Brands Global Stock

Dine Brands Stock Faces Potential Downturn

1 month ago
Intel Stock

US Government Considers Taking Equity Stake in Intel

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Procter & Gamble Shares Approach a Critical Juncture

Trending

XRP Stock
Analysis

XRP Market Dynamics: Institutional Pause Meets Accumulation Surge

by Andreas Sommer
January 11, 2026
0

The XRP market is currently defined by a stark divergence in investor behavior. After a powerful rally...

Rocket Lab USA Stock

Rocket Lab’s Stock Momentum Continues Unabated in 2026

January 11, 2026
Eli Lilly Stock

Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

January 11, 2026
Alibaba Stock

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

January 11, 2026
Vulcan Energy Stock

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • XRP Market Dynamics: Institutional Pause Meets Accumulation Surge
  • Rocket Lab’s Stock Momentum Continues Unabated in 2026
  • Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com